Xinlei Pan

Years Active: 2018-2019
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Suryavathi Viswanadhapalli, Yiliao Luo, Gangadhara R Sareddy, Bindu Santhamma, Mei Zhou, Mengxing Li, Shihong Ma, Rajni Sonavane, Uday P Pratap, Kristin A Altwegg, Xiaonan Li, Annabel Chang, Alejandra Chávez-Riveros, Kalarickal V Dileep, Kam Y J Zhang, Xinlei Pan, Ramachandran Murali, Marek Bajda, Ganesh V Raj, Andrew J Brenner, Vijaya Manthati, Manjeet K Rao, Rajeshwar R Tekmal, Hareesh B Nair, Klaus J Nickisch, Ratna K Vadlamudi
EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer. Molecular cancer therapeutics 18 (8) (2019)
Mirja Rotinen, Sungyong You, Julie Yang, Simon G Coetzee, Mariana Reis-Sobreiro, Wen-Chin Huang, Fangjin Huang, Xinlei Pan, Alberto Yáñez, Dennis J Hazelett, Chia-Yi Chu, Kenneth Steadman, Colm M Morrissey, Peter S Nelson, Eva Corey, Leland W K Chung, Stephen J Freedland, Dolores Di Vizio, Isla P Garraway, Ramachandran Murali, Beatrice S Knudsen, Michael R Freeman
ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis. Nature medicine 24 (12) (2018)

Xinlei Pan.css-eqlu8i{font-size:small;padding-left:4px;}